Tevogen Inc.
TVGN
Last
$7.09
Day
-1.8%
1y
-80.5%
5y
-98.6%
52w
-81.9%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1334d
EMA 21
7.00
EMA 50
6.99
EMA 200
13.07
20d high
-10.6%
5y high
-99.3%
5y range
0th
Positions held
Your positionsTVGN isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
12
Hold
watch
Signal
Neutral
Target
$8.25
Stop
$6.07
Stop distance
14.4%
Target vs last
+16.4%
Fundamentals
| Market cap | $45.97M | Enterprise value | $63.13M | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | -1.58 | Beta | 0.20 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | — | ROA | -3.0% | Debt / equity | — |
| Current ratio | 0.33 | Free cash flow | -$3.05M | Analyst recommendation | none | Mean target | — |
| 52w high | $39.00 | 52w low | $3.64 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$5.8M | -$5.4M | -$4.7M | -$5.7M | -$5.5M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$5.7M | -$5.4M | -$4.6M | -$5.7M | -$5.4M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$26.3M | -$13.7M | -$60.5M | $4.4M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$26.1M | -$53.6M | -$8.8M | -$1.0M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · UPDATE – Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC
2026-10-08 · Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC
2026-09-30 · Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements
2026-07-29 · Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
2026-07-14 · Tevogen Bio Announces 2026 Annual Meeting of Stockholders
Price (daily)
Full chart · RSI · MACD · patternsTVGN · daily-5.0% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin